Skip to main content
TipRanks
Go Ultimate75% OFF

Intellia Therapeutics (38I) Ownership - Who Owns Intellia Therapeutics?

0 Followers

Intellia Therapeutics (38I) Ownership Overview

  • 1.83% Insiders
  • 19.22% Mutual Funds
  • 43.04% Other Institutional Investors
  • 33.72% ETFs
  • 2.20% Public Companies and Individual Investors

The ownership structure of Intellia Therapeutics (CH:38I) stock is a mix of institutional, retail, and individual investors. Approximately 95.98% of the company’s stock is owned by Institutional Investors, 1.83% is owned by Insiders, and 2.20% is owned by Public Companies and Individual Investors.

Institutional holdings as of (latest 13F reporting period).

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Jul 23, 2026Edward J Iii Dulac$91,249
Jul 05, 2026Michael P Dube$44,316
Mar 02, 2026Eliana Clark$8,364
Jan 06, 2026John M. Leonard$314,485

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue
Dec 31, 2025Graham Capital Management, L.p.CHF263,820
Dec 31, 2025Bridgewater Associates, LpCHF2,006,262
Dec 31, 2025Ark Investment Management LlcCHF127,723,842

Top Shareholders

CH:38I top shareholders
Holder# of SharesType% HoldingValue
Ark18,518,707Institution13.19%211,613,265
BlackRock, Inc.16,035,423Institution11.42%183,236,779
Cathie Wood15,925,221Institution11.35%181,977,500
Vanguard11,251,893Institution8.02%128,575,381
Vanguard Index Funds10,795,618Institution7.69%123,361,527
Ishares6,798,660Institution4.84%77,688,288
Spdr5,111,220Institution3.64%58,405,911
Peter Kolchinsky4,526,926Institution3.23%51,729,183
Fidelity Select Portfolios3,080,133Institution2.19%35,196,680
Fidelity Salem Street Trust1,688,868Institution1.20%19,298,695

Top Mutual Fund Holders

CH:38I top mutual fund holders
Holder# of SharesType% HoldingValue
Vanguard Index Funds10,795,618Institution7.69%123,361,527
Fidelity Select Portfolios3,080,133Institution2.19%35,196,680
Fidelity Salem Street Trust1,688,868Institution1.20%19,298,695
Blackrock Funds1,309,189Institution0.93%14,960,103
Fidelity Concord Street Trust1,292,058Institution0.92%14,764,347
Dfa Investment Dimensions Group Inc1,281,309Institution0.91%14,641,518
Vanguard Horizon Funds1,027,324Institution0.73%11,739,231
Vanguard Scottsdale Funds888,693Institution0.63%10,155,095
Federated Hermes Mdt Series820,243Institution0.58%9,372,917
Fidelity Rutland Square Trust Ii707,056Institution0.50%8,079,529

FAQ

Who Owns Intellia Therapeutics (CH:38I)?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 95.98% of the company's stock is held by institutional investors, 1.83% is held by insiders, and 2.20% is held by public companies and individual investors.
What percentage of Intellia Therapeutics (CH:38I) stock is held by institutional investors?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 95.98% of Intellia Therapeutics (CH:38I) stock is held by institutional investors: 19.22% by mutual funds, 33.72% by ETFs and 43.04% by other institutional investors.
What percentage of Intellia Therapeutics (CH:38I) stock is held by retail investors?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 2.20% of Intellia Therapeutics (CH:38I) stock is held by public companies and individual investors.
Who owns the most shares of Intellia Therapeutics (CH:38I)?
ARK owns the most shares of Intellia Therapeutics (CH:38I).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.